SMTL ID : 4do3.1

Structure of FAAH with a non-steroidal anti-inflammatory drug

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.25 Å

Oligo State

homo-dimer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 4 residues within 4Å: Chain A: N.249, W.546 Chain B: N.249, W.546 Ligand excluded by PLIP

2 x OHO: CYCLOHEXANE AMINOCARBOXYLIC ACID(Covalent)

OHO.2: 10 residues within 4Å: Chain A: L.182, S.183, D.227, I.228, G.229, G.230, S.231, L.370, I.481 Ligands: 0LA.3 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.182, A:L.182, A:I.228, A:L.370, A:I.481 Hydrogen bonds: A:S.183, A:I.228, A:G.229, A:G.230, A:S.231 Water bridges: A:S.207 OHO.4: 9 residues within 4Å: Chain B: L.182, S.183, S.207, I.228, G.229, G.230, S.231, I.481 Ligands: 0LA.5 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:L.182, B:L.182, B:I.228, B:I.481 Hydrogen bonds: B:S.183, B:S.183, B:I.228, B:G.229, B:G.230, B:S.231 Water bridges: B:S.207

2 x 0LA: (2S)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid(Non-covalent)

0LA.3: 9 residues within 4Å: Chain A: L.182, F.371, L.394, F.422, M.426, G.475, T.478, W.521 Ligands: OHO.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.182, A:F.371, A:F.422, A:T.478, A:W.521 Hydrogen bonds: A:D.393 Water bridges: A:G.475, A:G.475, A:T.478 0LA.5: 9 residues within 4Å: Chain B: L.182, F.371, L.394, I.397, F.422, M.426, T.478, W.521 Ligands: OHO.4 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:L.182, B:F.371, B:L.394, B:I.397, B:F.422, B:T.478, B:W.521 Hydrogen bonds: B:T.478, B:W.521 Water bridges: B:G.475

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bertolacci, L. et al., A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase. J.Am.Chem.Soc. (2013)

Release Date

2013-01-23

Peptides

Fatty-acid amide hydrolase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Fatty-acid amide hydrolase 1